Alseroxylon
Appearance
Clinical data | |
---|---|
ATC code | |
Identifiers | |
CAS Number | |
DrugBank | |
ChemSpider |
|
UNII | |
ChEMBL | |
Chemical and physical data | |
Formula | Varies |
(what is this?) (verify) |
Alseroxylon (Rautensin, Rauwiloid) is a norepinephrine reuptake inhibitor that has been investigated in the treatment of hypertension[1] and angina pectoris and as a sedative in psychoses.[2] It was at one time approved for use in the United States, but has since been discontinued.[3]
Alseroxylon is a purified fat-soluble extract of the root of Rauvolfia serpentina, containing reserpine and other nonadrenolytic amorphous alkaloids.[2]
References
- ^ Green, R. S.; Davolos, D. (1956). "A long-term study of the effect of crude Rauwolfia serpentina and of its alseroxylon fraction in patients with hypertension". The American Journal of Medicine. 20 (5): 760–773. doi:10.1016/0002-9343(56)90158-9. PMID 13313574.
- ^ a b DrugBank DB00386
- ^ Approved Drug Products with Therapeutic Equivalence Evaluations (33rd ed.). 2013.
{{cite book}}
:|work=
ignored (help)